PAPER Louis ED, Benito-León J

Alzheimer's disease, Parkinson's disease and essential tremor: three common degenerative diseases with shared mechanisms?

Eur J Neurol. 2010 Jun 1;17(6):765-6. PubMed: 20192981

PAPER Feuillette S, Miguel L, Frébourg T, Campion D, Lecourtois M

Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.

J Neurochem. 2010 May;113(4):895-903. PubMed: 20193038

PAPER Tian G, Kong Q, Lai L, Ray-Chaudhury A, Lin CL

Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.

J Neurochem. 2010 May;113(4):978-89. PubMed: 20193040

PAPER Zhao QL, Zhou Y, Wang YL, Dong KH, Wang YJ

A new diagnostic algorithm for vascular cognitive impairment: the proposed criteria and evaluation of its reliability and validity.

Chin Med J (Engl). 2010 Feb 5;123(3):311-9. PubMed: 20193251

PAPER Cao Y, Ravid R, Guan ZZ

[Changes in expression of synaptic proteins in brains of patients with Alzheimer's disease].

Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):833-4. PubMed: 20193460

PAPER Zambón D, Quintana M, Mata P, Alonso R, Benavent J, Cruz-Sánchez F, Gich J, Pocoví M, Civeira F, Capurro S, Bachman D, Sambamurti K, Nicholas J, Pappolla MA

Higher incidence of mild cognitive impairment in familial hypercholesterolemia.

Am J Med. 2010 Mar;123(3):267-74. PubMed: 20193836

PAPER Giorgetti M, Gibbons JA, Bernales S, Alfaro IE, Drieu La Rochelle C, Cremers T, Altar CA, Wronski R, Hutter-Paier B, Protter AA

Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism.

J Pharmacol Exp Ther. 2010 Jun;333(3):748-57. PubMed: 20194526

PAPER Ohe K, Mayeda A

HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease.

Mol Cell Biol. 2010 May;30(9):2220-8. PubMed: 20194618

PAPER Yuri Jang, Kim G, Chiriboga D

Knowledge of Alzheimer's disease, feelings of shame, and awareness of services among Korean American elders.

J Aging Health. 2010 Jun;22(4):419-33. PubMed: 20194682

PAPER Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Mol Neurobiol. 2010 Jun;41(2-3):73-86. PubMed: 20195796

PAPER Lue LF, Kuo YM, Beach T, Walker DG

Microglia activation and anti-inflammatory regulation in Alzheimer's disease.

Mol Neurobiol. 2010 Jun;41(2-3):115-28. PubMed: 20195797

PAPER Wolf RC, Uttner I, Osterfeld ND

[Depressive symptoms in a case of "posterior cortical atrophy"].

Fortschr Neurol Psychiatr. 2010 Apr;78(4):226-9. PubMed: 20195949

PAPER Iova A, Mihancea P, Sabău M

General aspects of the morbidity in Alzheimer's dementia during 2003-2005 at the Neurology and Psychiatry Clinical Hospital Oradea.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1089-92. PubMed: 20191879

PAPER Boyle PA, Buchman AS, Barnes LL, Bennett DA

Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons.

Arch Gen Psychiatry. 2010 Mar;67(3):304-10. PubMed: 20194831

SNX1

ANTIBODY kit manufacturer Cat# H00006642-AP21<br /> Produced by Abnova Capture antibody: rabbit MaxPab® affinity purified polyclonal anti-SNX1; Detection antibody: mouse purified polyclonal anti-SNX1 SNX1-sorting nexin 1 Protein Trafficking Novus Biologicals